Marker Therapeutics logo

Marker Therapeutics Share Price (NASDAQ: MRKR)

$0.93

0.03

(3.33%)

Last updated on

Check the interactive Marker Therapeutics Stock chart to analyse performance

Marker Therapeutics stock performance

as on September 2, 2025 at 11:40 pm IST

  • Today's Low:$0.90
    Today's High:$0.97

    Day's Volatility :7.22%

  • 52 Weeks Low:$0.81
    52 Weeks High:$5.95

    52 Weeks Volatility :86.39%

Marker Therapeutics Stock Returns

PeriodMarker Therapeutics IncIndex (Russel 2000)
3 Months
-39.1%
0.0%
6 Months
-32.92%
0.0%
1 Year
-69.55%
0.0%
3 Years
-69.54%
-2.3%

Marker Therapeutics Inc Key Stats

Check Marker Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.93
Open
$0.9576
Today's High
$0.91
Today's Low
$0.8754
Market Capitalization
$12.0M
Today's Volume
$597.2K
52 Week High
$5.95
52 Week Low
$0.8099
Revenue TTM
$5.4M
EBITDA
$-11.8M
Earnings Per Share (EPS)
$-1.35
Profit Margin
-271.11%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-144.68%

Stock Returns calculator for Marker Therapeutics Stock including INR - Dollar returns

The Marker Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Marker Therapeutics investment value today

Current value as on today

₹35,618

Returns

₹64,382

(-64.38%)

Returns from Marker Therapeutics Stock

₹69,408 (-69.41%)

Dollar Returns*

₹5,026 (+5.03%)

Indian investors sentiment towards Marker Therapeutics Stock

-68%

Period: Aug 2, 2025 to Sep 1, 2025. Change in 30 Days versus previous period

Search interest for Marker Therapeutics Stock from India on INDmoney has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Marker Therapeutics Inc

  • Name

    Holdings %

  • NEA Management Company, LLC

    14.37%

  • Blue Owl Capital Holdings LP

    4.90%

  • Hudson Bay Capital Management LP

    4.42%

  • Aisling Capital Management LP

    2.88%

  • Vanguard Group Inc

    2.43%

  • Alyeska Investment Group, L.P.

    1.88%

Analyst Recommendation on Marker Therapeutics Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Marker Therapeutics(by analysts ranked 0 to 5 stars)

Marker Therapeutics Share Price Target

What analysts predicted

Upside of 545.16%

Target:

$6.00

Current:

$0.93

Marker Therapeutics share price target is $6.00, a slight Upside of 545.16% compared to current price of $0.93 as per analysts' prediction.

Marker Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, MRKR stock has moved down by -7.4%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 349.10K → 861.18K (in $), with an average increase of 59.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -4.44M → -4.01M (in $), with an average increase of 10.7% per quarter
  • MRKR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.0% return, outperforming this stock by 144.4%
  • MRKR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 117.3% return, outperforming this stock by 186.9%
  • Price to Sales

    ForMRKR every $1 of sales, investors are willing to pay $1.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Marker Therapeutics Technicals Summary

Sell

Neutral

Buy

Marker Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Marker Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Marker Therapeutics Inc logo
-25.35%
-32.92%
-69.55%
-69.54%
-94.18%
Regeneron Pharmaceuticals, Inc. logo
1.6%
-14.03%
-50.32%
1.17%
0.57%
Beone Medicines Ltd logo
0.58%
18.94%
62.57%
87.24%
31.49%
Vertex Pharmaceuticals Incorporated logo
-17.2%
-19.58%
-17.8%
40.06%
46.22%
Alnylam Pharmaceuticals, Inc. logo
6.42%
83.8%
75.94%
121.86%
256.67%

About Marker Therapeutics Inc

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Organization
Marker Therapeutics
Employees
5
CEO
Dr. Juan F. Vera M.D.
Industry
Consumer Services

Key Management of Marker Therapeutics Inc

NameTitle
Dr. Juan F. Vera M.D.
Co-Founder, CEO, President, Treasurer, Secretary & Director
Ms. Elizabeth Donnelly
Director of Administration
Dr. Maria-Bernadette Madel Ph.D.
Director of Corporate Operations & External Communications
Mr. Edmund Cheung
Vice President of Human Resources
Patricia Allison
Head of Clinical Operations
Ms. Mary Newman Ph.D.
Head of Regulatory Affairs
Dr. Robert Z. Florkiewicz Sr., Ph.D.
Senior Director of Molecular Biology & Virology

Important FAQs about investing in MRKR Stock from India :

What is Marker Therapeutics share price today?

Marker Therapeutics share price today is $0.93 as on at the close of the market. Marker Therapeutics share today touched a day high of $0.97 and a low of $0.90.

What is the 52 week high and 52 week low for Marker Therapeutics share?

Marker Therapeutics share touched a 52 week high of $5.95 and a 52 week low of $0.81. Marker Therapeutics stock price today i.e. is closed at $0.93, lower by 84.37% versus the 52 week high.

How to invest in Marker Therapeutics Stock (MRKR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Marker Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Marker Therapeutics Shares that will get you 1.6129 shares as per Marker Therapeutics share price of $0.93 per share as on September 2, 2025 at 11:40 pm IST.

What is the minimum amount required to buy Marker Therapeutics Stock (MRKR) from India?

Indian investors can start investing in Marker Therapeutics (MRKR) shares with as little as ₹88.148 or $1 (as of September 02, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.48 in Marker Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 02, 2025). Based on Marker Therapeutics share’s latest price of $0.93 as on September 2, 2025 at 11:40 pm IST, you will get 10.7527 shares of Marker Therapeutics. Learn more about fractional shares .

What are the returns that Marker Therapeutics has given to Indian investors in the last 5 years?

Marker Therapeutics stock has given -94.18% share price returns and 20.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?